3Yao FY, Terrault NA, Freise C, et al. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation : a comparative study using a matched, untreated cohort. Hapetology, 2001,34 : 411-416.
5Wong F, Blengis L. New challenge of hepatorenal ayndrume: prevention and treatmnet[J]. Hepatology, 2001, 34(6):1242-1251.
6Hann HW, Fontana RJ, Wright T, et al. A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.Liver Transpl, 2003, 9: 49-56.
7Oh JM, Kyun J, Cho SW. Long-term lamivudine therapy for chronic hepatitis B in patients with and without cirrhosis. Pharmacotherapy,2002, 22: 1226-1234.
8Villeneuve JE Condreay LD, Willems B, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology, 2000, 31: 207-210.
9Yao FY, Terrault NA, Freise C, et al. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation:a comparative study using a matched, untreated cohort. Hepatology,2001. 34:411-416.
10Yao FY, Bass NM. Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection. J Hepatol, 2000, 33: 301-307.
